| Literature DB >> 6835690 |
P A Chapelle, F Blanquart, A J Puech, J P Held.
Abstract
The authors describe a new therapy for paraplegic anejaculation. Sub-cutaneous injection of Physostigmine with certain precautions and with selected methods of application can be used for patients where there is the same indication for the use of an intrathecal injection of Neostigmine. The T12-L2 myelomeres must be intact. The new treatment is easier to perform, and when the patient has experimented with three tests in our hospital without any problems, he is granted permission to apply this treatment at home, without any medical supervision.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6835690 DOI： 10.1038/sc.1983.5
Source DB: PubMed Journal: Paraplegia ISSN： 0031-1758